ACTIVE

BIOWIN

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-13,4 k €-142,5 %over 1 year
Gross margin1,1 M €+27,5 %over 1 year
Equity300,8 k €-4,3 %over 1 year
Workforce7,6 ETP+22,6 %over 1 year

Identity

Source · BCE/KBO

BIOWIN is a Non-profit organization incorporated in 2006. Its main activity is: Other professional, scientific and technical activities. Its registered office is in Namur. It employs on average 7,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0882.768.591
Incorporation
28/07/2006
Legal form
Non-profit organization
Registered office
Avenue d'Ecolys(RH) 2 box 29
5020 Namur · WallonieSee on map
Latest accounts
31/12/2025
Average workforce
7,6 ETP
Joint committees (1)
  • 337
Signals
Good liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 18 financial years

20252024202320222021
Income statement
Gross margin1,1 M €833,4 k €481,6 k €661,6 k €713,8 k €
EBITDA82,5 k €101,2 k €-115,7 k €121,4 k €133,6 k €
Operating result-8,3 k €82,2 k €-61,8 k €55,5 k €142,1 k €
Net result-13,4 k €31,6 k €-73 k €48,2 k €121,5 k €
Balance sheet
Equity300,8 k €314,2 k €282,7 k €355,7 k €307,5 k €
Total assets1,1 M €1,5 M €1,2 M €991,8 k €1,3 M €
Cash141,2 k €735,8 k €514,2 k €430,5 k €608,7 k €
Debts738,4 k €412,8 k €420,2 k €348,7 k €351 k €
Other
Workforce7,6 ETP6,2 ETP5,9 ETP5,9 ETP6,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

15 active · 34 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Ion Beam Applications0428.750.985Represented by Cristiana Gameiro-Paris
Director19/01/2018 → 05/06/2026Mandate2022 accountsended
NOVADIP BIOSCIENCES0535.575.602Represented by Denis Dufrane
Director12/06/2025 → 05/06/2026
Telix Pharmaceuticals (Belgium)0695.832.765Represented by Sébastien Linard
Director12/06/2025 → 05/06/2026
CER-Groupe0420.654.158Represented by OLIVIER VANLOOCKE
Director01/01/2015 → 15/06/2026Mandate2022 accountsended
COMUNICARE SOLUTIONS0686.922.227Represented by ALFRED ATTIPOE
Director15/06/2023 → 15/06/2026
EXO Biologics0732.982.379Represented by HUGUES WALLEMACQ
Director15/06/2023 → 15/06/2026
EYED PHARMA0508.599.605Represented by MELANIE MESTDAGT
Director30/06/2019 → 15/06/2026Mandate2022 accountsended
GlaxoSmithKline Biologicals0440.872.918Represented by PHILIPPE DENOEL
Director01/01/2015 → 15/06/2026Vice-chairman of the board of directors17/06/2020 → 2020 accountsendedChairman of the board of directors19/01/2018 → 2021 accountsendedMandate2022 accountsended
KANEKA EUROGENTEC0427.348.346Represented by FLORENCE XHONNEUX
Director01/01/2015 → 15/06/2026Chairman of the board of directors01/01/2015 → 2016 accountsendedMandate2022 accountsended
UCB PHARMA0403.096.168Represented by Xavier Hormaechea
Director01/01/2015 → 15/06/2026Mandate2022 accountsended
Université Catholique de Louvain0419.052.272Represented by JEAN-CHRISTOPHE RENAULD
Director01/01/2015 → 15/06/2026Mandate2022 accountsended
Université de Liège - Communauté française0807.970.507Represented by BRIGITTE MALGRANGE
Director19/01/2018 → 15/06/2026Vice-chairman of the board of directors17/06/2020 → 2020 accountsendedMandate2022 accountsended
UNIVERSITE DE MONS0259.396.509Represented by ANNE-EMILIE DECLEVES
Director15/06/2023 → 15/06/2026
Université de Namur0409.530.535Represented by CARINE MICHIELS
Director01/01/2015 → 15/06/2026Mandate2022 accountsended
Université Libre de Bruxelles0407.626.464Represented by SERGE SCHIFFMANN
Director01/01/2015 → 15/06/2026Vice-chairman of the board of directors01/01/2015 → 2019 accountsended

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Barré0448.409.224Represented by JAVIER MARTINEZ
Director15/06/2023 → 2024 accounts
BAXALTA BELGIUM MANUFACTURING0563.700.454Represented by VALERIE DE SCHUTTER
Director15/06/2023 → 2024 accounts
CorQuest MedTech0733.537.853Represented by OLIVIER DE CUYPERE
Director15/06/2023 → 2024 accounts
UNIVERCELLS0502.742.288Represented by HUGUES BULTOT
Director15/06/2023 → 2024 accounts

Other companies at this address

Avenue d'Ecolys(RH) 2 5020 Namur
CompanyCBE no.
A.A.S.V.● Active
0430.121.358
Actibel Hôtel● Active
0654.752.968
ACTIBEL IMMOBILIER● Active
0460.782.662
ACTIBEL MOBILITY● Active
0673.597.395
ACTIONAM● Active
0440.996.840
ACTION II● Active
0449.242.236
A-DJ SERVICES● Active
0862.601.006
Annet 4 Future● Active
0791.919.678
Antech Diagnostics Belgium● Active
0820.954.154
ANTIQUITES ACHAT - VENTE● Active
0463.017.622
AQUALE● Active
0477.877.428
AQUALYS MANAGEMENT● Active
1021.551.738
AVESTA Insurance● Active
0797.621.102
Aves TVA● Active
0804.855.718
A-Z ServiPro● Active
0462.702.668
BDG Ansotte● Active
1016.456.862
B.G.N INVEST● Active
0804.639.744
BN 4● Active
0859.854.619
CAVI● Active
0440.893.605
CCB & PARTNERS● Active
1016.343.927

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202618/07/202527/05/202528/08/202322/07/202209/08/2021
General meeting05/06/202612/06/202513/06/202415/06/202321/06/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202505/06/202630/06/2026FrenchPDF
Abridged model31/12/202412/06/202518/07/2025FrenchPDF
Abridged modelCorrection31/12/202313/06/202427/05/2025FrenchPDF
Abridged model31/12/202313/06/202418/06/2024FrenchPDF
Abridged model31/12/202215/06/202328/08/2023FrenchPDF
Abridged model31/12/202121/06/202222/07/2022FrenchPDF
Abridged model31/12/202007/06/202109/08/2021FrenchPDF
Abridged model31/12/201917/06/202030/07/2020FrenchPDF
Abridged model31/12/201820/06/201908/08/2019FrenchPDF
Abridged model31/12/201713/06/201831/08/2018FrenchPDF
Abridged model31/12/201613/06/201727/07/2017FrenchPDF
Abridged model31/12/201503/06/201630/08/2016FrenchPDF
Abridged model31/12/201404/06/201530/06/2015FrenchPDF
Abridged model31/12/201316/06/201423/12/2014FrenchPDF
Abridged model31/12/201217/06/201323/07/2013FrenchPDF
Abridged model31/12/201114/05/201217/01/2013FrenchPDF
Abridged model31/12/201006/06/201102/05/2012FrenchPDF
Abridged model31/12/200927/05/201017/09/2010FrenchPDF
Abridged model31/12/200816/06/200908/01/2010FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

15 active · 34 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Ion Beam Applications0428.750.985Represented by Cristiana Gameiro-Paris
Director19/01/2018 → 05/06/2026Mandate2022 accountsended
NOVADIP BIOSCIENCES0535.575.602Represented by Denis Dufrane
Director12/06/2025 → 05/06/2026
Telix Pharmaceuticals (Belgium)0695.832.765Represented by Sébastien Linard
Director12/06/2025 → 05/06/2026
CER-Groupe0420.654.158Represented by OLIVIER VANLOOCKE
Director01/01/2015 → 15/06/2026Mandate2022 accountsended
COMUNICARE SOLUTIONS0686.922.227Represented by ALFRED ATTIPOE
Director15/06/2023 → 15/06/2026
EXO Biologics0732.982.379Represented by HUGUES WALLEMACQ
Director15/06/2023 → 15/06/2026
EYED PHARMA0508.599.605Represented by MELANIE MESTDAGT
Director30/06/2019 → 15/06/2026Mandate2022 accountsended
GlaxoSmithKline Biologicals0440.872.918Represented by PHILIPPE DENOEL
Director01/01/2015 → 15/06/2026Vice-chairman of the board of directors17/06/2020 → 2020 accountsendedChairman of the board of directors19/01/2018 → 2021 accountsendedMandate2022 accountsended
KANEKA EUROGENTEC0427.348.346Represented by FLORENCE XHONNEUX
Director01/01/2015 → 15/06/2026Chairman of the board of directors01/01/2015 → 2016 accountsendedMandate2022 accountsended
UCB PHARMA0403.096.168Represented by Xavier Hormaechea
Director01/01/2015 → 15/06/2026Mandate2022 accountsended
Université Catholique de Louvain0419.052.272Represented by JEAN-CHRISTOPHE RENAULD
Director01/01/2015 → 15/06/2026Mandate2022 accountsended
Université de Liège - Communauté française0807.970.507Represented by BRIGITTE MALGRANGE
Director19/01/2018 → 15/06/2026Vice-chairman of the board of directors17/06/2020 → 2020 accountsendedMandate2022 accountsended
UNIVERSITE DE MONS0259.396.509Represented by ANNE-EMILIE DECLEVES
Director15/06/2023 → 15/06/2026
Université de Namur0409.530.535Represented by CARINE MICHIELS
Director01/01/2015 → 15/06/2026Mandate2022 accountsended
Université Libre de Bruxelles0407.626.464Represented by SERGE SCHIFFMANN
Director01/01/2015 → 15/06/2026Vice-chairman of the board of directors01/01/2015 → 2019 accountsended

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Barré0448.409.224Represented by JAVIER MARTINEZ
Director15/06/2023 → 2024 accounts
BAXALTA BELGIUM MANUFACTURING0563.700.454Represented by VALERIE DE SCHUTTER
Director15/06/2023 → 2024 accounts
CorQuest MedTech0733.537.853Represented by OLIVIER DE CUYPERE
Director15/06/2023 → 2024 accounts
UNIVERCELLS0502.742.288Represented by HUGUES BULTOT
Director15/06/2023 → 2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates07/08/2026
    Nominations d'administrateurs - Présidence et vice-présidence du conseil
    PDF
  • Mandates10/12/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates20/02/2024
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates01/02/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Other21/11/2016
    Pour l'article 2 :
    PDF
  • Mandates23/09/2016
    Nominations et Démissions - Pouvoirs - Changement de siège social.
    PDF
  • Other20/02/2014
    Composition du Conseil d'Administration
    PDF
  • Other20/02/2014
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings18 filings
Mandates
Ion Beam Applications
NOVADIP BIOSCIENCES
Telix Pharmaceuticals (Belgium)
UNIVERSITE DE MONS
UCB PHARMA
Université Libre de Bruxelles
Université de Namur
Université Catholique de Louvain
CER-Groupe
KANEKA EUROGENTEC
GlaxoSmithKline Biologicals
EYED PHARMA
200620072008200920102011201220132014201520162017201820192020202120222023202420252026
BIOWIN
Avenue d'Ecolys(RH) 2 bte 29, 5020 ChampionRue Auguste Piccard 20, 6041 Gosselies
Director
Director
Director
Director
Director
DirectorVice-chairman of the board of directors
Director
Director
Director
DirectorChairman of the board of directors
DirectorChairman of the board of directors
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Avenue d'Ecolys(RH) 2 bte 29, 5020 ChampionCurrent
accounts 2023 → 2025
Accounts 2025 · 2026-00222510
Rue Auguste Piccard 20, 6041 Gosselies
accounts 2021 → 2022
Accounts 2022 · 2023-00359847

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
BIOWINCurrent
accounts 2008 → 2025
Accounts 2025 · 2026-00222510

Events

  1. 2025
    Annual accounts 2025-13,4 k €↓
  2. 2024
    Annual accounts 202431,6 k €↑
  3. 2023
    Annual accounts 2023-73 k €↓
  4. 2022
    Annual accounts 202248,2 k €↓
  5. 2021
    Annual accounts 2021121,5 k €↑
  6. 2020
    Annual accounts 2020-9,4 k €↑
  7. 2019
    Annual accounts 2019-72,7 k €↓
  8. 2018
    Annual accounts 2018229,7 k €↑
  9. 2017
    Annual accounts 20171,2 k €↓
  10. 2016
    Annual accounts 201663,7 k €↓
  11. 2015
    Annual accounts 201572,2 k €↑
  12. 2014
    Annual accounts 2014-29 k €↑
  13. 2013
    Annual accounts 2013-192,2 k €↓
  14. 2012
    Annual accounts 201217 k €↑
  15. 2011
    Annual accounts 2011-83 k €↓
  16. 2010
    Annual accounts 2010101,9 k €↑
  17. 2009
    Annual accounts 2009-77,2 k €↓
  18. 2008
    Annual accounts 200876,6 k €
  19. 28/07/2006
    IncorporationNon-profit organization